BRCA1 and hyperinsulinemic hypoglycemia, familial, 4: In agreement with these reports, TH5487 was shown to enhance the sensitivity to the PARP inhibitor Olaparib, in particular in the context of BRCA1 deficiency (Baquero et al., 2022).